First Time Into Human Studies

MHRA accredited standards

The MHRA accreditation scheme provides a seal of quality for all studies conducted under this scheme by setting and enforcing minimum standards across the UK. Our all-encompassing MHRA accredited Phase 1 units are located within of two of the United Kingdom’s largest NHS hospitals and thus are the safest environments available for your clinical trial. Our study experience includes those studies that require submission to the Expert Advisory Group (EAG) i.e. those studies where our extra provision of care provides you with peace of mind.

Rapid approval

The UK has an industry focussed well organised clinical trial approval system. As a long established Phase I unit we have an excellent track record of starting studies on time by effectively managing ethics and regulatory approvals. Our processes ensure a minimum of queries and rejection letters as they are tailored around regulatory and ethical requirements in the UK.

Extensive experience

We conduct a wide range of First in Human studies and our extensive experience stretches from therapeutic areas to research methodologies. However, we want to be the best in our field and therefore we specialise in four fields:

• First time into human studies
• TQT studies
• Japanese and Japanese bridging studies
• Patient recruitment

Sponsors actively seek out Richmond Pharmacology because of our expertise in conducting highly complex studies in those areas and it is very common that protocols would combine two or more of our core competencies.

Quickly adapt to change

Our location within and our partnership with acute NHS hospitals ensures we have direct on-site integration with regard to medical support meaning adverse events can be assessed and treated by specialists in the shortest possible time. This in turn ensures that your study will remain on track in case of the unexpected.